Business Wire

Industry Veterans Appointed to Head the Global Technical Operations and Clinical Development Organizations at Kite

Share

Kite, a Gilead Company (Nasdaq: GILD), today announced two new additions to the company’s leadership team. Charles Calderaro will join Kite as Global Head of Technical Operations, and Ken Takeshita, MD will join as Global Head of Clinical Development. Both Mr. Calderaro and Dr. Takeshita will report directly to Christi Shaw, Chief Executive Officer of Kite.

“Innovation in manufacturing and scientific advancement are dually critical to the delivery and continued progress of cell therapy,” said Ms. Shaw. “We are pleased to welcome Charles and Ken, whose deep and diverse experience will bolster Kite’s leadership in cell therapy and ensure that we are best positioned to meet the needs of patients now and well into the future.”

Mr. Calderaro will be responsible for leading all aspects of Kite’s technical operations, including process development, manufacturing, supply chain management, quality assurance and end-to-end optimization for the company’s commercial and pipeline products, effective December 9, 2019. He joins Kite from BioMarin Pharmaceutical Inc., where he currently holds the position of Senior Vice President, Global Manufacturing and is responsible for the strategic oversight and leadership of the company’s international operations network. Previous to this, Mr. Calderaro was the Vice President of Technical Product Management at Genentech leading the CMC life cycle management of the company’s small molecule product portfolio in Basel, Switzerland.

“I am impressed with Kite’s R&D and manufacturing excellence, which have had a dramatic impact on the treatment of cancer and really helped set the company apart,” said Mr. Calderaro. “I look forward to bringing my experience to the company and to working with the many talented individuals dedicated to changing the way this disease is treated.”

Dr. Takeshita will head Kite’s cell therapy clinical development organization, including the company’s pipeline in solid tumor research, effective December 3, 2019. He joins Kite from Sorrento Therapeutics, Inc., where he is currently Senior Vice President, Clinical Research, responsible for clinical development strategy in oncology. His previous experience includes many years at Celgene Corporation, where he was Corporate Vice President for Clinical R&D and the Therapeutic Area Head for Lymphoma and CLL.

“It is a privilege to have the opportunity to contribute to Kite’s industry-leading cell therapy clinical development program,” said Dr. Takeshita. “I am excited by the company’s pipeline and consistent commitment to next-generation science, and look forward to helping further the team’s collective mission.”

About Kite

Kite, a Gilead Company, is a biopharmaceutical company based in Santa Monica, California. Kite is engaged in the development of innovative cancer immunotherapies. The company is focused on chimeric antigen receptor and T cell receptor engineered cell therapies. For more information on Kite, please visit www.kitepharma.com.

About Gilead Sciences

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California. For more information on Gilead Sciences, please visit the company’s website at www.gilead.com.

For more information on Kite, please visit the company’s website at www.kitepharma.com. Learn more about Gilead at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.

Contact information

Greg Mann, Investors
(424) 322-1795

Shant Salakian, Media
(424) 384-1841

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Ipsen Initiates Partial Clinical Hold for Palovarotene IND120181 and IND135403 Studies6.12.2019 06:00:00 CETPress release

Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced, following discussions with the U.S. Food and Drug Administration (FDA), that a partial clinical hold effective immediately, for the pediatric population under the age of 14 was issued for studies conducted under IND120181 and IND135403 evaluating the investigational drug candidate palovarotene for the chronic treatment of fibrodysplasia ossificans progressiva (FOP) and multiple osteochondromas (MO), respectively. The partial clinical hold applies to the pediatric population (patients under the age of 14 years) currently participating in the Phase 2 (PVO-1A-202/204 and PVO-2A-201) and Phase 3 (PVO-1A-301) studies in all clinical sites at global level. The FDA is allowing the studies to continue to treat patients 14 years of age and older. The partial clinical hold was issued following recent safety reports submitted by the company to the FDA of cases of early growth plate closure in pediatric patients with FOP treated w

 Panasonic and KOSÉ Set to Commence Verification Test for Personalized Proposals Utilizing Snow Beauty Mirror6.12.2019 02:37:00 CETPress release

Panasonic Corporation is collaborating with KOSÉ Corporation to conduct a joint verification test using Snow Beauty Mirror, a system under development by Panasonic, with the aim of offering personalized proposals at Maison KOSÉ, a store which is due to open on December 17. Through this initiative, Panasonic will help make new personalized proposals that meet the diverse needs of its customers. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191205005971/en/ Snow Beauty Mirror (Displays the results of skin analysis covering five categories) (Photo: Business Wire) People’s values and lifestyles are becoming increasingly diverse. In today’s world, everyone requires something different from their cosmetics. Meanwhile, customers are confronted with a deluge of information through the Internet and social media, which sometimes makes it difficult for them to select cosmetics that really suit their needs. A solution to this conundrum

Citi Private Bank Issues Outlook 2020: Global Growth Can Endure Over the Coming Year5.12.2019 18:30:00 CETPress release

Citi Private Bank today released its Outlook report for 2020, titled, “Staying Positive in a Negative (Yielding) World.” The twice-yearly publication provides in-depth insights into the global economy and financial markets for the coming year, and highlights important multi-year investment themes for client portfolios. The report highlights Citi Private Bank’s view that global economic growth can endure through 2020 given expectations that corporate earnings will continue to grow at a solid pace; global equities may continue to rise higher; and with global fixed income yields at record lows, they anticipate the sector will continue to struggle in 2020. “The year ahead promises to be an eventful year for investors,” said David Bailin, Chief Investment Officer, Citi Private Bank. “Our Outlook 2020 cuts through the noise and focuses on what really matters for our clients’ wealth and provides sector recommendations to potentially enhance total return profiles.” He continued, “We believe gl

Kanguru Leaps Over The Competition With A New OS Agnostic Encrypted Fingerprint Access Flash Drive5.12.2019 16:31:00 CETPress release

Kanguru is proud to announce the launch of the world’s first OS Agnostic, Fingerprint Access Hardware Encrypted Flash Drive with remote management capability. This new biometric fingerprint access flash drive supplants the bulky pinpads and fussy combo keypads of leading encrypted devices, making it much more convenient and easy to use. With just a tap of the finger, the new Kanguru Defender Bio-Elite30™ Fingerprint Hardware Encrypted Flash Drive provides quick access to encrypted files. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191205005662/en/ The New Kanguru Defender Bio-Elite30 Fingerprint Hardware Encrypted Flash Drive is OS Agnostic, remotely manageable, and provides best-in-class encryption with easy fingerprint access! (Photo: Business Wire) Being OS Agnostic, the Defender Bio-Elite30 can be used on virtually any machine, from Windows and MacOS, to medical equipment, smart TVs and even ATMs for making bank machi

Sensor Electronic Technology Obtains Permanent Injunction Against U.S. UV LED Companies5.12.2019 14:00:00 CETPress release

Sensor Electronic Technology, Inc. (“SETi”), a leading global innovator of deep UV LED products and technology, announced that it successfully obtained a permanent injunction in a patent infringement lawsuit against Bolb, Inc. (“Bolb”), and Quantum Egg, Inc. (“Q-Egg”). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191205005031/en/ The history of UV LED business (Graphic: Business Wire) The California Northern District federal court issued a permanent injunction against the sales of an accused UV LED sterilizer device, as well as any mere colorable variations, according to the parties’ stipulation. The Court will therefore prohibit the sale of similar products if they prove to be mere colorable variations of the accused products. The asserted patents in this litigation cover fundamental UV LED technology, encompassing UV LED sterilizer structures and drivers, chip fabrication, and epitaxial layer growth. Bolb is a UV LED com

SHRM--Society for Human Resource Management and Prometric Renew Long-Term Partnership with Multi-year Agreement5.12.2019 14:00:00 CETPress release

Following a comprehensive procurement process, we’re excited to announce that SHRM--Society for Human Resource Management®, the voice of all things work, has selected Prometric® as its strategic testing partner. Under the renewal, Prometric will assist in the delivery of the SHRM Certified Professional (SHRM-CP®) and SHRM Senior Certified Professional (SHRM-SCP®) exam programs—the global certification standard for the HR profession. This agreement extends the partnership between the organizations that started in 2010. Since inception of the certification program in 2014, Prometric has partnered with SHRM to deliver more than 75,000 exams globally with over 90% growth since the first administration. With businesses increasingly recognizing that effective people management is a strategic imperative, leaders now expect HR professionals to also demonstrate the behavioral competencies required to effectively apply knowledge in the modern workplace. By incorporating key HR competencies and k